Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed with results

Key Signals

3 with results86% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (7)
P 4 (1)

Trial Status

Completed6
Recruiting2
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (9)

Research Network

Activity Timeline